Categories: Technology

Gaxos Labs Unveils Visual Editor for Godot Gaming Engine

| Source: GAXOS.AI INC.

Roseland, NJ, Dec. 06, 2024 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that the Company released a visual editor for Godot Engine for their artificial intelligence solution for game developers and publishers, Gaxos Labs. The Godot visual editor introduces a user-friendly interface that simplifies the process of embedding AI-driven features directly into game projects.

“We are thrilled to bring this powerful new tool to the Godot community,” said Vadim Mats, CEO of Gaxos. “In addition to our API that can be used with any game development engine, we strive to make game development simpler through our visual editors, tools and artificial intelligence integrations.

For more information, visit Gaxos Labs where you’ll find more information on Gaxos Labs and all it offers game developers and players. You can also follow Gaxos Labs on X, Facebook, or Gaxos.ai on LinkedIn for the latest updates and news. 

About Godot

Godot is a free, open-source game development engine that gives developers the ability to create 2D and 3D games, cross-platform projects, and more. It is known for its flexibility, user-friendly interface, and robust community.

About Gaxos.ai Inc.

Gaxos.AI isn’t just developing applications; it’s redefining the human-AI relationship. Our offerings span health and wellness as well as gaming. We’re committed to addressing health, longevity, and entertainment, through AI solutions. 

Forward-Looking Statements

All statements other than statements of historical fact in this announcement are forward-looking statements that involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC.

Gaxos.ai Inc. Company Contact

Investor Relations
E:ir@gaxos.ai
T: 1-888-319-2499

GlobeNews Wire

Recent Posts

Chery Debuts All-New HIMLA Series at 2025 Shanghai Auto Show, Redefining the Pickup Market with Full-Category Lineup

SHANGHAI, April 26, 2025 /PRNewswire/ -- On April 23, under the spotlight at 2025 Shanghai…

4 hours ago

Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

April 26, 2025 10:00 ET  | Source: Protara Therapeutics TARA-002 demonstrates 100% complete response rate…

6 hours ago

RAD-140 SARMs Rad 140 Testolone Benefits, Dosage, Safety, and Where to Buy Sarms Online (by Crazy Bulk USA)

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- The fitness and bodybuilding industry is constantly…

6 hours ago

Prime Biome (Ive Tested It for 90 Days) Heres My Honest Prime Biome Gummies Review And Shocking Results! (Good, Bad & Real)

LOS ANGELES, April 26, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a rigorously developed herbal…

6 hours ago

GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting

GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV…

6 hours ago

Burnjaro Under Review: Analyzing the Results of Burn Jaro Slimming Ingredients to Instantly Burn Belly Fat

Norcross, Georgia, April 26, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why belly…

6 hours ago